These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 11513351)
1. Cognitive decline in schizophrenics with Alzheimer's disease: a mini-review of neuropsychological and neuropathological studies. Niizato K; Genda K; Nakamura R; Iritani S; Ikeda K Prog Neuropsychopharmacol Biol Psychiatry; 2001 Oct; 25(7):1359-66. PubMed ID: 11513351 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282 [TBL] [Abstract][Full Text] [Related]
3. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease. Davidson M; Harvey P; Welsh KA; Powchik P; Putnam KM; Mohs RC Am J Psychiatry; 1996 Oct; 153(10):1274-9. PubMed ID: 8831434 [TBL] [Abstract][Full Text] [Related]
4. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease. Löwe LC; Gaser C; Franke K; PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological investigation of the background of cognitive decline in elderly schizophrenia. Miwa A; Hirano M; Torii Y; Sekiguchi H; Habuchi C; Fujishiro H; Yoshida M; Iwai K; Kawashima K; Iritani S Acta Neuropsychiatr; 2021 Apr; 33(2):85-91. PubMed ID: 33143788 [TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment in elderly schizophrenia: a dementia (still) lacking distinctive histopathology. Arnold SE; Trojanowski JQ Schizophr Bull; 1996; 22(1):5-9. PubMed ID: 8685663 [TBL] [Abstract][Full Text] [Related]
7. A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia. Casanova MF; Carosella NW; Gold JM; Kleinman JE; Weinberger DR; Powers RE Psychiatry Res; 1993 Oct; 49(1):41-62. PubMed ID: 8140181 [TBL] [Abstract][Full Text] [Related]
8. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Friedman JI; Harvey PD; Coleman T; Moriarty PJ; Bowie C; Parrella M; White L; Adler D; Davis KL Am J Psychiatry; 2001 Sep; 158(9):1441-8. PubMed ID: 11532729 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease. Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669 [TBL] [Abstract][Full Text] [Related]
10. Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease. McBride T; Moberg PJ; Arnold SE; Mozley LH; Mahr RN; Gibney M; Kumar A; Gur RE Schizophr Res; 2002 Jun; 55(3):217-27. PubMed ID: 12048145 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder. Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication. Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750 [TBL] [Abstract][Full Text] [Related]
13. Scores Obtained from a Simple Cognitive Test of Visuospatial Episodic Memory Performed Decades before Death Are Associated with the Ultimate Presence of Alzheimer Disease Pathology. Robinson AC; McNamee R; Davidson YS; Horan MA; Snowden JS; McInnes L; Pendleton N; Mann DMA Dement Geriatr Cogn Disord; 2018; 45(1-2):79-90. PubMed ID: 29694971 [TBL] [Abstract][Full Text] [Related]
14. Contributions of neuropathology to understanding schizophrenia in late life. Arnold SE Harv Rev Psychiatry; 2001; 9(2):69-76. PubMed ID: 11266404 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Bennett DA; Wilson RS; Schneider JA; Evans DA; Aggarwal NT; Arnold SE; Cochran EJ; Berry-Kravis E; Bienias JL Neurology; 2003 Jan; 60(2):246-52. PubMed ID: 12552039 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Dal Forno G; Rasmusson DX; Brandt J; Carson KA; Brookmeyer R; Troncoso J; Kawas CH Arch Neurol; 1996 Apr; 53(4):345-50. PubMed ID: 8929157 [TBL] [Abstract][Full Text] [Related]
17. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e. Susanto TA; Pua EP; Zhou J; J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955 [TBL] [Abstract][Full Text] [Related]
18. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years. Wattmo C; Wallin ÅK Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660 [TBL] [Abstract][Full Text] [Related]
19. No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics. Murphy GM; Lim KO; Wieneke M; Ellis WG; Forno LS; Hoff AL; Nordahl T Biol Psychiatry; 1998 Feb; 43(3):205-9. PubMed ID: 9494702 [TBL] [Abstract][Full Text] [Related]
20. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Driscoll I; Resnick SM; Troncoso JC; An Y; O'Brien R; Zonderman AB Ann Neurol; 2006 Dec; 60(6):688-95. PubMed ID: 17192929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]